secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001193125-26-096709
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.02, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences raises ~$240M in private placement; prelim cash ~$188M
------------------------------------------------------------------------

- Gross proceeds ~$240M from 14.97M shares at $5.61 and 27.81M pre-funded warrants at $5.609.
- Preliminary cash, equivalents and securities ~$187.9M as of Dec 31, 2025 (unaudited).
- Net proceeds extend runway into H1 2028; funds pipeline development, BD, and G&A.
- Investors include Perceptive Advisors, Bain Capital Life Sciences, RA Capital Management, Invus, and others.
- Private placement expected to close March 9, 2026; Leerink and Citi lead placement agents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312526096709/0001193125-26-096709-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312526096709/d81855d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-096709

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer